A Danish start-up, BioPhenyx, has developed a functional genetic assay that uses CRISPR to evaluate the effects of any mutation of interest. The...

The state of play in the field of CRISPR diagnostics has been changing rapidly. Here, Bryan DeChairo, CEO of Sherlock Biosciences, discusses the...

A new electrochemical biosensor combines an aptamer capable of binding to pathogenic bacteria with CRISPR-Cas12a through a primer exchange reaction....

As the COVID-19 pandemic continues to evolve with fluctuating restrictions worldwide, mass vaccine rollouts and the emergence of new variants, it's...

Extremely precise biosensors embedded into clothing could inform doctors or scientists that they've been exposed to a dangerous germ. The sensors can...

This week’s update looks at a CRISPR-Cas12a-based detection method, developed in China as a confirmatory tool to aid SARS-CoV-2 diagnosis.

This week’s clinical update looks at a trial to evaluate a combined CRISPR-Cas12a/PCR detection strategy to direct early and targeted anti-infective...

The new electric field-driven 'lab-on-a-chip' use CRISPR-Cas12 to rapidly detect the SARS-CoV-2 in nasal-swap samples. The device is portable and can...